Ng George K 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-01-30$2.70/sh+10,000$27,000→ 20,000 total(indirect: By Trust)
Footnotes (2)
- [F1]Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F2]Reflects that shares previously reported as directly held by the reporting person were held in a trust.